公司发布 2025 上半年业绩公告。2025H1 公司实现营业收入 93.9 亿元，同比增长 21.06%，实现 净利润 9.06 亿元，同比下滑 23.1%，实现经调整归母净利润 12.8 亿，同比增长 3%。2025Q2 公司 实现营业收入 49.66 亿元，同比增长 23%，实现净利润 4.9 亿元，同比下降 16.67%，实现经调整 净利润 6.9 亿元，同比增长 10.6%。调整项主要包含收购永辉股权的银行贷款的利息开支、与股 票挂钩证券有关的利息开支以及分占永辉亏损等。 ► 25Q2 收入增长环比提速，国内及海外同店持续向好 证券研究报告|港股公司点评报告 [Table_Date] 2025 年 08 月 25 日 [Table_Title] Q2 盈利能力环比改善，发力自有 IP 矩阵 [Table_Title2] 名创优品(9896.HK) | [Table_DataInfo] 评级： | 增持 | 股票代码： | 9896 | | --- | --- | --- | --- | | 上次评级： | 增持 | 52 周最高价/最低价(港元)： | 51.05/25.05 | | 目标价格(港元 ...

丨证券研究报告丨 港股研究丨公司点评丨中国生物制药（1177.HK） [Table_Title] 财务增长强劲，创新持续爆发 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 报告要点 [Table_Summary] 2025H1 中国生物制药实现营收 175.7 亿元（同比+10.7%），持续经营业务归母净利润 33.9 亿 元翻倍大增（同比+140.2%）。创新产品收入及占比快速攀升，占总收入比例达 44.4%。公司以 5 亿美元全资收购礼新医药，整合其四大抗体与 ADC 技术平台，推进至少 6 项核心管线转化。 分析师及联系人 [Table_Author] 彭英骐 刘长洪 SAC：S0490524030005 SAC：S0490525070007 SFC：BUZ392 中国生物制药（1177.HK） cjzqdt11111 [Table_Title2] 财务增长强劲，创新持续爆发 [Table_Summary2] 事件描述 2025 年 8 月 18 日，中国生物制药发布 2025 年中期业绩公告：2025 年上半年实现营业收入 175.7 亿元，同比增长 ...

Investment Rating - The report maintains a "Buy" rating for China Biopharmaceutical (1177.HK) [6][3] Core Views - The company reported a revenue of 17.57 billion yuan (+10.7%) and a net profit attributable to shareholders of 3.39 billion yuan (+140.2%) for the first half of 2025, exceeding profit growth expectations [1][6] - The innovative product line is driving high growth, with two new innovative products approved by NMPA in the first half of 2025, contributing to an innovative product revenue of 7.8 billion yuan (+27.2%), accounting for 44.4% of total revenue [1][2] - The company expects nearly 20 innovative products to be approved from 2025 to 2027, with over half projected to have peak sales exceeding 2 billion yuan [2] Financial Performance - For 2025, the company forecasts revenues of 32.78 billion yuan, a growth of 13.6%, and a net profit of 4.81 billion yuan, a growth of 37.5% [3][4] - The projected earnings per share (EPS) for 2025 is 0.26 yuan, with a price-to-earnings (P/E) ratio of 29.08 [4][11] - The company anticipates that the proportion of revenue from innovative products will increase to 50% by 2027 [2][3] Business Segments - The oncology segment achieved a revenue of 6.694 billion yuan (+24.9%) in the first half of 2025, while the surgical/pain management segment generated 3.105 billion yuan (+20.2%) [1][2]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% relative to the industry index in the next six months [4]. Core Insights - The company's profitability continues to improve, with strong order growth and robust performance in AI commercialization. For the first half of 2025, the company achieved a revenue of 930 million yuan, a year-on-year increase of 25.5%, and a net profit attributable to shareholders of 37.38 million yuan, marking a return to profitability [1][2]. - The AI+SaaS business segment shows strong growth, with a revenue of 500 million yuan in the first half of 2025, up 26.0% year-on-year, and a significant order growth of 69.1%, laying a solid foundation for revenue growth in the second half of 2025 [2]. - The company has been enhancing its AI Agent product matrix, with AI revenue reaching 110 million yuan in the first half of 2025, and the annual recurring revenue (ARR) reaching 190 million yuan. The introduction of new AI products is expected to further accelerate commercialization in the second half of 2025 [3]. Financial Summary - The company is projected to achieve revenues of 2.358 billion yuan, 3.179 billion yuan, and 4.142 billion yuan for the years 2025, 2026, and 2027, respectively, with adjusted net profits of 112 million yuan, 203 million yuan, and 299 million yuan for the same years [4]. - The company's revenue growth rates are forecasted at 51.3%, 34.8%, and 30.3% for 2025, 2026, and 2027, respectively, while the adjusted net profit growth rates are expected to be 106.4%, 131.2%, and 75.1% for the same periods [1][4].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The controlling shareholder, He Xiaopeng, increased his stake in the company, purchasing a total of 3.1 million Class A ordinary shares at an average price of HKD 80.49 per share, resulting in an ownership of approximately 18.9% [2][4]. - The company is expected to see accelerated sales growth due to its leading smart driving capabilities, a strong new vehicle cycle, channel transformation, and enhanced marketing systems [2][8]. - The financial outlook is positive, with anticipated improvements driven by scale expansion, cost reductions from platform and technology, and the ongoing growth of software profitability and international sales [2][8]. Summary by Sections Event Description - On August 21, 2025, the company announced that He Xiaopeng purchased 3.1 million Class A ordinary shares through his wholly-owned company, Galaxy Dynasty Limited, at an average price of HKD 80.49 per share [4]. Sales and Financial Performance - The company reported a Q2 automotive gross margin of 14.3%, exceeding expectations, and anticipates Q3 delivery volumes of 113,000 to 118,000 vehicles, representing a year-on-year growth of 142.8% to 153.6% [8]. - Expected revenue for Q3 is projected to be between CNY 19.6 billion and CNY 21 billion, reflecting a year-on-year increase of 94.0% to 107.9% [8]. - The new models, including the P7 and G6, have received strong market responses, with pre-sales exceeding 10,000 units within minutes [8]. Strategic Partnerships and Market Expansion - The company is deepening its collaboration with Volkswagen, expanding the partnership to include traditional fuel and hybrid vehicles, which is expected to enhance service revenue [8]. - International sales have surged, with Q2 2025 overseas sales reaching 11,000 units, a year-on-year increase of 150.2% and a quarter-on-quarter increase of 45.6% [8].

Investment Rating - The investment rating for the company is "Outperform" (maintained) [3] Core Views - The company's mid-year performance for 2025 met expectations, with a revenue of 3.104 billion RMB, a year-on-year decrease of 6.1%, and a net profit attributable to shareholders of 289 million RMB, a year-on-year increase of 2.2% [7] - The company aims to build a Chinese luxury brand management group, showcasing strong multi-brand operational capabilities, and is expected to exhibit stronger growth momentum under new positioning and management upgrades [7] Financial Data and Profit Forecast - Revenue and profit forecasts for the company are as follows: - FY2023: Revenue 6,912 million RMB, Net Profit 838 million RMB - FY2024: Revenue 6,589 million RMB, Net Profit 469 million RMB - FY2025E: Revenue 6,360 million RMB, Net Profit 510 million RMB - FY2026E: Revenue 6,678 million RMB, Net Profit 550 million RMB - FY2027E: Revenue 6,999 million RMB, Net Profit 590 million RMB - The company’s revenue growth rates are projected to be -5% for FY2024 and -3% for FY2025E, with a recovery expected in FY2026 and FY2027 at 5% [7][20] Brand Performance - The performance of various brands showed divergence: - Koradior: Revenue of 1.04 billion RMB, down 1.2% year-on-year - NAERSI: Revenue of 655 million RMB, down 10.9% year-on-year - NEXY.CO: Revenue of 484 million RMB, down 4.0% year-on-year - La Koradior: Revenue of 280 million RMB, up 9.7% year-on-year [17] Channel Analysis - E-commerce maintained growth for 12 consecutive years, with online sales increasing by 8.9% to 595 million RMB, accounting for 19.2% of total revenue [7] - Offline store optimization led to a net closure of 74 stores, with a focus on shopping centers, resulting in a 7.7% decrease in direct retail revenue to 2.431 billion RMB [7] Cost Control and Profitability - The company achieved significant cost control, with a stable gross margin of 76.4% and a decrease in selling and administrative expenses [7] - The net cash flow from operating activities for the first half of 2025 was 896 million RMB, a substantial increase of 98.3% year-on-year [7] Valuation Comparison - The company is compared with peers such as Jiangnan Buyi and Jin Hong Group, with an expected PE ratio of 10 times for 2025, indicating a potential upside of 13% from the current market value [7][11]

Investment Rating - The report maintains a "Buy" rating for Bilibili-W (09626) [8] Core Insights - Bilibili achieved a revenue of 7.34 billion yuan in Q2 2025, representing a year-on-year growth of 20%, slightly exceeding Bloomberg consensus expectations [2] - The adjusted net profit attributable to shareholders was 560 million yuan, with a profit margin of 7.7%, marking a turnaround from losses in the previous year and surpassing Bloomberg consensus by 8% [2] - User growth remains strong, with a monthly active user (MAU) count of 363 million, up 8% year-on-year, and daily active users (DAU) at 109 million, up 7% [8] - Advertising revenue in Q2 2025 reached 2.45 billion yuan, also up 20% year-on-year, with expectations for continued strong growth in the second half of the year [8] - The gaming segment reported revenue of 1.61 billion yuan, a significant increase of 60% year-on-year, driven by new game releases [8] - The value-added services segment generated 2.84 billion yuan in revenue, an 11% increase year-on-year, with a notable rise in membership subscriptions [8] - The gross margin for Q2 2025 was 36.5%, with a continuous improvement trend over the past 12 quarters [8] - The report projects adjusted net profits for 2025, 2026, and 2027 to be 2.45 billion, 3.28 billion, and 4.19 billion yuan respectively, reflecting an upward revision from previous forecasts [8] Financial Data and Profit Forecast - Revenue projections for Bilibili are as follows: - 2023: 22.53 billion yuan - 2024: 26.83 billion yuan - 2025E: 29.97 billion yuan - 2026E: 32.90 billion yuan - 2027E: 35.46 billion yuan [4] - The adjusted net profit forecast is as follows: - 2023: -3.43 billion yuan - 2024: -0.02 billion yuan - 2025E: 2.45 billion yuan - 2026E: 3.28 billion yuan - 2027E: 4.19 billion yuan [4] - Earnings per share (EPS) projections are: - 2023: -8.29 yuan - 2024: -0.05 yuan - 2025E: 5.83 yuan - 2026E: 7.80 yuan - 2027E: 9.96 yuan [4]

Investment Rating - The investment rating for TCL Electronics is "Buy" with a target price not specified [5][4]. Core Views - TCL Electronics is a leading player in the global TV industry, with a focus on high-end products and global operations driving steady market share expansion [4]. - The company has shown strong revenue growth in various segments, particularly in the display business and internet services, indicating robust operational performance [2][3]. - The strategic focus on cost control and efficiency improvements has led to enhanced profitability, with adjusted net profit showing significant year-on-year growth [3][4]. Summary by Sections Financial Performance - For the first half of 2025, TCL Electronics reported revenue of HKD 54.78 billion, a year-on-year increase of 20.4%, and an adjusted net profit of HKD 1.06 billion, up 62% [1]. - The display business generated revenue of HKD 33.42 billion, with significant contributions from large-size displays and smart commercial displays [2]. Business Segments - The display segment saw a revenue increase of 10.9%, with large-size displays growing by 9.4% and smart commercial displays by 9.4% [2]. - Internet business revenue rose by 20.3% to HKD 1.46 billion, with overseas revenue increasing by 46.3% [2]. - The photovoltaic business experienced remarkable growth, with revenue up 111.3% to HKD 11.14 billion [2]. Profitability and Cost Management - The overall gross margin for the first half of 2025 was 15.3%, slightly down by 0.6 percentage points due to a higher proportion of low-margin photovoltaic business [3]. - The company effectively reduced its overall expense ratio, leading to an increase in adjusted net profit margin by 0.5 percentage points to 1.9% [3]. Future Outlook - TCL Electronics is actively expanding into new business areas such as smart glasses and companion robots, with significant market share achievements in these segments [3]. - The company is expected to maintain strong growth in adjusted net profit, projected at HKD 2.34 billion, HKD 2.84 billion, and HKD 3.35 billion for 2025, 2026, and 2027 respectively [4].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company's overall performance in H1 2025 shows total revenue of 1.821 billion HKD, a year-on-year increase of 12.3%. Adjusted net profit attributable to shareholders reached 467 million HKD, up 71.3% year-on-year, with a gross margin of 73.6%, an increase of 8.7 percentage points [4][6] - The revenue from the imaging and design product segment was 1.351 billion HKD, growing 45.2% year-on-year, accounting for 74.2% of total revenue. Advertising revenue was 434 million HKD, up 5.0%, while revenue from beauty solutions declined by 88.9% to 30 million HKD due to a strategic focus on core business [4][5] Summary by Sections Financial Performance - In H1 2025, the company achieved total revenue of 1.821 billion HKD, a 12.3% increase year-on-year. Adjusted net profit was 467 million HKD, reflecting a 71.3% year-on-year growth. The gross margin improved to 73.6%, up 8.7 percentage points [4][6] - The revenue breakdown shows imaging and design products at 1.351 billion HKD (45.2% growth), advertising at 434 million HKD (5.0% growth), and beauty solutions at 30 million HKD (88.9% decline) [4][5] User Growth and Global Strategy - As of June 2025, the company's global monthly active users (MAU) reached 280 million, a year-on-year increase of 8.5%. Notably, overseas users grew to 98 million (35% of total), up 15.3%, significantly outpacing domestic growth [5] - The introduction of AI features, such as "AI Dressing," has been well-received in markets like Southeast Asia, the US, and the UK, contributing to user growth. The "AI Flashlight" feature reached approximately 1.9 million users in its first month [5] AI-Driven Product Innovation - AI technology has significantly enhanced the product matrix, increasing user willingness to pay. By June 2025, paid subscription users reached approximately 15.4 million, a growth of over 42.0%, with a penetration rate of 5.5% [6] - The company launched the AI design assistant RoboNeo in July 2025, which quickly surpassed one million MAU without relying on the existing product matrix. A complete subscription and purchase mechanism is expected to be launched by late August or early September [6] Investment Recommendations - The report maintains a positive outlook on the company's ability to further increase its conversion rate due to AI enhancements. Projected revenues for 2025-2027 are 4.016 billion HKD, 5.053 billion HKD, and 6.105 billion HKD, representing year-on-year growth rates of 20.2%, 25.8%, and 20.8% respectively. Non-IFRS net profit is expected to be 950 million HKD, 1.189 billion HKD, and 1.558 billion HKD, with growth rates of 62.1%, 25.1%, and 31.1% respectively [6][9]

Investment Rating - The investment rating for the company is "Buy" and it is maintained [10] Core Views - The company achieved steady growth in revenue and net profit attributable to shareholders in the first half of 2025, with net profit growth outpacing revenue growth due to an increase in gross margin [2][7] - The current valuation does not fully reflect the short-term operational improvements and long-term competitive advantages of the company, which emphasizes shareholder returns with a high dividend yield [2][11] Summary by Sections Financial Performance - In the first half of 2025, the company reported revenue of 34.2 billion and a net profit attributable to shareholders of 910 million, representing year-on-year growth of 4.2% and 11.8% respectively [7] - The gross margin improved by 1.0 percentage point to 12.9% year-on-year, contributing to the better performance of net profit compared to revenue [11] Sales and Land Acquisition - The company demonstrated strong sales performance with a sales amount of 70.7 billion (up 7%) and an equity sales amount of 53.4 billion (up 5%), with an average selling price of 26,506 per square meter (up 25%) [11] - The company adopted a "speed first, with profitability" land acquisition strategy, achieving a new land value of 98.7 billion (up 33%) in the first half of 2025 [11] Asset Quality and Financial Health - The company’s inventory value from projects acquired in 2021 and earlier was 47.4 billion, down approximately 3 billion from the end of 2024, indicating improved asset quality [11] - The financing cost decreased to 3.17% as of June 2025, down 39 basis points from the end of 2024, reflecting a strong financial safety margin [11] Future Outlook - The company is expected to achieve net profits of 4.91 billion, 5.31 billion, and 5.88 billion for the years 2025, 2026, and 2027, representing year-on-year growth of 2.1%, 8.2%, and 10.8% respectively [11] - The current valuation corresponds to price-to-earnings ratios of 7.7, 7.1, and 6.4 for the respective years, indicating significant investment value [11]